Management of advanced NK/T-cell lymphoma

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Nasal/nasopharyngeal natural killer/T-cell lymphomas (NK/T-cell lymphomas) are aggressive hematologic malignancies.
• Conventional anthracycline regimens, designed for B-cell lymphomas, yield poor outcomes in NK/T-cell lymphomas.
• L-asparaginase-containing regimens have become the standard of care, significantly improving treatment outcomes.

Purpose of the Study:

• To address the unsatisfactory outcomes in advanced NK/T-cell lymphomas, where only 50% achieve durable remission.
• To identify the need for improved patient stratification in advanced NK/T-cell lymphomas to guide intensified therapy for poor-risk individuals.
• To evaluate novel prognostic factors beyond conventional parameters for patients receiving L-asparaginase-based treatments.

Main Methods:

• Review of current treatment strategies and outcomes for NK/T-cell lymphomas.
• Analysis of the inadequacy of conventional presentation parameters for prognostication with L-asparaginase regimens.
• Exploration of dynamic interim assessment factors, including Epstein-Barr virus (EBV) DNA levels and positron emission tomography-computed tomography (PET-CT) findings.

Main Results:

• L-asparaginase-containing regimens represent a significant advancement but do not fully resolve challenges in advanced NK/T-cell lymphomas.
• Conventional clinical parameters appear insufficient for accurate prognostication in the era of L-asparaginase therapy.
• Interim treatment assessment using dynamic factors like EBV DNA quantification and PET-CT findings shows potential for superior patient stratification.

Conclusions:

• Improved risk stratification is crucial for patients with advanced NK/T-cell lymphomas to optimize treatment strategies.
• Dynamic monitoring of biomarkers such as EBV DNA and imaging findings (PET-CT) offers a promising approach for prognostication.
• Further evaluation of high-dose chemotherapy and stem cell transplantation within a risk-adapted framework is warranted.